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Objectives: to test the hypotheszs that mtravascular hght could be dehvered vza a balloon catheter for artemal photodynamzc 
therapy (PDT) 
Design: pig non-injury model 
Materials: chnzcaI catheter eqzupment. 
Methods: large Whzte pzgs (15-20pg) were photosensttzsed wtth 5-ammolaevuhmc acid (5-ALA) induced protoporphyrm 
IX (PplX) at a concentratzon of 120 mg/kg Arterial biopsws were taken at mtervals between 30 rams and 24 h and fi'ozen 
sections analysed using a CCD camera to gzve a temporal profile of fluorescence m each arterzaI layer. PDT was gzven 
to normal arterial segments vza a 4mm transparent PTA balloon inflated so as to occlude flow, but not dzstend the artely. 
Ammals were culled at 3 and 14 days and the above segments harvested. 
Results: fluorescence peaked m the advent#za, zntzma nd medzal ayers at 1 5, 4 and 6h respectzvely PDT at all tzme 
points produced VSMC depletzon compared wzth controls. The degree of depletton mzrrored the fluorescence profile of 
PpIX 
Conclusions: PDT can be dehvered wa a standard PTA balloon wzth a transparent channel Ttus depletes the VSMC 
population w#hm the arterzaI wall wzthout comphcatzons. Intra-artenal PDT is therefore a potentzaI therapy to reduce 
the mczdence of restenoszs post-angzoplasty. 
Key Words Photodynamtc herapy; AngtopIasty, Restenoszs. 
Introduction probably eqmvalent, but the data is less accurate due 
to lack of angiographic follow-up. 
During the last two decades, percutaneous trans- The mechanisms behind the restenosls process are 
luminal angioplasty (PTA) has become estabhshed in still not fully understood and it is therefore not sur- 
the treatment of atherosclerotic coronary and peri- prising that currently there are no proven therapeutic 
pheral arterial disease. Advances in catheter design options to prevent it in chmcal practice. Much effort 
and improved techniques have allowed more complex has gone into trying to prevent the intimal hyperplastic 
and more distal stenoses and occlusions to be suc- response to bal looninjury and following Austin's post- 
cessfully treated leading to excellent immediate "radio- mortem studies, 7 the natural target for such work has 
logical" results. However, such results are, in some been the vascular smooth muscle cell (VSMC). In the 
cases, shorthved as it is now accepted that 12-50% of porcine restenosis model it has been established that 
all PTAs restenose within 6 months post-procedure. 1-4 VSMC proliferation and matrix formation are the major 
In Holmes' report of follow-up angiography from the contributors to neozntima formation. 8 This was initially 
PTCA Registry, 5 the restenosis rate was found to be believed to be the sole mechanism of restenosls until 
definition dependent, but the overall rate was 34% more recent studies 9-15 in both animal and human 
from centres with combined repeat angioplasty rate studies have revealed a remodellmg component. Re- 
of 84% of all cases. Moreover, in cases which restenose, modelling describes changes in all vascular dimensions 
the majority do so within 3 months with a small following injury which may be favourable where the 
additional number between 3 and 6 months. 6Reported vessel (and lumen) increase m size, or unfavourable 
restenosis rates following peripheral angioplasty are where there is a reduction in the external elastic lamina 
as well as intimal hyperplasia resulting in lumen lOSS. 9 
It is now established that remodelling contributes more 
to restenosis than neointimal hyperplasia following 
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c/o Freyer Ward, Middlesex Hospital, Mortimer Street, London angioplasty alone, but since stenting limits the effects 
WIN 8AA U K of remodelling on lumen area, restenosis following 
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stenting is almost exclusively secondary to neointlmal the cooperation of the named veterinary surgeon. Six 
hyperplasia. 16Up to 70% of coronary angioplasties Large White/Landrace crossbred pigs were an- 
are now stented, so a method of reducing neomtima aesthetised with inhaled halothane following pre- 
formation remains an important goal. medication with mtra-muscular medetomidine hydro- 
Photodynamic therapy (PDT) produces a tissue chloride at 10-20~tg/kg. Animals were intubated and 
effect by a photochemical reaction (following the inter- maintained under spontaneous respiration with a mix- 
action of light and a photosensitising agent) which ture of halothane, nitrous oxide and oxygen at 1.5%, 
allows reactive intermediates to cause cellular death. 0.5 and 41/mm respectively. 5-ALA (Dusa, U.S.A.) 
It has already been established in work with tumours, was given in an intravenous preparation (buffered to 
that rapidly proliferating tissues how partial (but, not pH 4.8 using 8.4% sodium bicarbonate) at a con- 
absolute I7) selectivity in the uptake of photosensitiser centration of 120mg/kg in a bolus injection via an ear 
and can therefore be targeted allowing relative sparing vein. 
of normal tissues The magnitude and depth of this Animals were cleaned and draped under sterile 
effect is known to be dependent on the type of photo- con&tions. In four animals sequential arterial biopsies 
sensitiser, the light dose and the interval between the were taken from time zero to 8h (at 30 min intervals 
photosensitiser and the light, to 2h and then hourly) and in two, 24 hour samples 
Vascular PDT has been shown to be effective in were taken following sensitisatlon the day before. 
depleting the VSMC population ~n vitro ~8"~9 and in small Biopsies were taken via longitudinal groin and neck 
animal studies 2°-24 using a variety of photosensitisers, approaches for access to external iliac and carotid 
without complications of thrombosis or aneurysm for- arteries respectively and were randomised with re- 
mation. However, the limitations of small animal spect to biopsy site and time point between animals. 
models are now clear a5-27 and if vascular PDT is to One centimetre transverse sections of arteries were 
be proposed as a therapy to prevent angloplasty re- excised between ligatures, snap frozen in precooled 
stenosis in humans it must first be shown to be effective isopentane and stored in liqmd nitrogen. Care was 
in a large animal model, taken to ensure that sequential biopsies were taken 
The development ofa new photosensitiser, 5-amino- from progressively more proximal sites which re- 
laevuhnic acid (5-ALA) has allowed PDT to be applied roamed perfused. 
to situations other than those requiring full thickness Three transverse frozen sections (10~tm thick) were 
necrosis 5-ALA induces endogenous porphyrin sens- cut from each block and stored at -20°C before 
itisation via an active metabolite, protoporphyrin IX being thawed just prior to fluorescence microscopy. 
(PpIX) which following interaction with red light pro- Fluorescence of PpIX was excited by a helium-neon 
duces cellular killing to a depth of lmm. In the treat- laser at 633nm and the signal detected between 665 
ment of malignancy, 5-ALA's depth of penetration is and 710nm by a cryogenically cooled CCD (charge- 
a disadvantage, but for vascular PDT it would be coupled device) camera fitted to the fluorescence 
suitable for treating the arterial wall while limiting microscope and linked to an IBM computer. False- 
damage to deeper tissue, colour images were generated and quantitative ana- 
For vascular PDT to be a feasible adjunctive therapy lysis performed by measuring the mean arbitrary pixel 
to prevent restensls following balloon angioplasty, count for each arterial ayer. Three sections per animal 
light would have to be delivered via an endovascular per time point were analysed and nine readings taken 
technique using a laser fibre delivering hght through from each sectmn; three from each of the adventitia, 
a balloon catheter. This study aimed to measure the media and intima. Background counts were peri- 
pharmacokinetics of PpIX (the active metabolite of 5- odmcally checked to confirm adequate quipment cool- 
ALA) in the arterial system and investigate the safety ing and autofluorescence from control (time zero) 
and efficacy of endovascular light delivery for PDT in sections ubtracted from each count. Mean counts for 
a swine model, each layer were then plotted for each time point. 
Methods PDT of normal arteries 
Pharmacokinetics of 5-ALA A further eight pigs were photosensitised with 120mg/ 
kg 5-ALA which was given as a bolus intravenous 
All animal studies were carried out under licence injection via an ear vein whilst under sedation Once 
(Animals (Scientific Procedures Act) 1986) and with photosensitised, pigs were kept in subdued light until 
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j 1950 sec. Post-procedure, patency was checked with a 
further angiogram and the process repeated in the 
' contralateral iliac artery. 
Arterial segments were treated at 1.5, 2.5 or 6-7h 
0 ~ ~ post-photosensitisation and control procedures - light 
~ ~ ~ alone (in an unphotosensitised animal) and balloon 
/ /  only (no light in a photosensitised animal) were per- 
b formed. Following completion, the introducer sheath 
< C was removed, the carotid ligated and the skin closed. 
/ Animals were recovered and kept in subdued light 
J/ for 24h. Aspirin (300mg) was given from 1 day pre- 
operatively until culling. 
Four animals were culled at 3, and 4 at 14 days 
postoperatively b a lethal dose of iv pentobarbitone. 
Control tissue was harvested at 3 days postoperatively. 
A bilateral retroperitoneal dissection was made to 
expose the treated iliac segments which were con- 
a d trolled with slings and clamped proximally and dist- 
ally. A 20FG intravenous catheter was inserted via a 
constant side branch and the segment pressure per- 
fused in situ with a 4% solution of formyl saline at 
Fig. 1. Schematic diagram to illustrate mtra-artemal PDT (a) Un- 100mmHg before excision. The excised artery was 
senmtlsed lhac artery, (b) artery following 5-ALA, (c) balloon catheter 
over gmdewlre deployed within artery; (d) laser fibre substituted ivided into proximal, middle and distal treated seg- 
for gmdewlre, hghtmg sensltlsed arterial segment ments and stored for 16 hours m 4% formyl saline 
fixative. Two transverse histological sections from each 
segment were stained with H and E and examined by 
anaesthetised, as before, and maintained with lnhala- light microscopy (Nikon Labophot-2) to assess the 
tlonal halothane and nitrous oxide. A 5 cm longitudinal number of VSMCs per high power field (HPF). Micro- 
incision was made in the left neck and the carotid scopy images were transferred onto a 486 personal 
exposed and controlled between slings. A 7FG sheath computer via a colour camera (JVC TK-1281) and 
was introduced over a guidewire via an arteriotomy morphometnc analysis performed using a Lucla-M 
and Seldinger technique and 5000 IU of heparin given (Version 3.52a) programme. Each section was imaged 
intra-arterially. A peripheral angiogram was per- and the number of VSMCs per HPF counted in four 
formed with 10ml of Omnipaque (350mgI/ml) and fields per section at 12, 3, 6 and 9 o'clock. Counts for 
stored on an image intensifier (Siemens) to produce a PDT treated segments were averaged and compared 
"road map", and under screening, a guidewire ad- with controls 
vanced into one common iliac artery. A 4mm/4cm Sections from one block obtained at each treatment 
transparent balloon catheter (Cordis, U.K ) was ad- time point were stained with polyclonal Factor VIII 
vanced over the wire and the balloon inflated within (Dako, Denmark) using a Strep-avidin horse radish 
the common iliac artery to 4 atmospheres (to occlude, peroxide techmque as a specific marker for endothelial 
but not distend the artery) and a further anglogram cells. These were examined by light microscopy. 
performed to confirm occlusion of the artery. The Statistical analysis between treatment subgroups 
guidewire was then removed and exchanged for a and controls was by analysis of variance (ANOVA) 
laser fibre with a 4cm 200gm radial diffuser at its tip using a Statview 4.5 computer programme (Abacus 
(Rare Earth Medical, U.S.A.) which was positioned Concepts, California). Subgroups were compared 
within the balloon segment, as illustrated schem- using Fishers' PLSD post hoc test if the F-value was 
atically m Fig. 1. Red light at a wavelength of 635nm significant. 
was generated from a copper vapour pumped dye 
laser (Oxford lasers) and 50 J per cm 2 of the surface Results 
of the inflated balloon given with a 60 second break 
in light delivery after 20% of the dose. During this Pharmacokmetzcs 
fractionation period when the laser was off, the balloon 
was deflated to perfuse the limb. The irradiation time False-colour images reveal high PpIX activity (highest 
required to generate 50J/cm 2 varied between 1350- intensity) in different arterial ayers at different time 
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Fig. 2. False-colour fluorescence images of transverse sections through arterial blopsms taken (a) 15h and(b) 7h following 5-ALA 
admlmstratlon. High adventltlal uptake is noted at 1 5h which is reduced by 7h, when maximum fluorescence is seen m the media L = 
lumen, I = mt~ma, M = media, A = adventltla 
100 [ ~- mation in any of the PDT treated or control segments. 
A transverse section of a treated and control artery is 
seen in Fig. 4 showing depletion of the VSMC popu- 
80 ~ lation in the segment which received PDT. Mean ( + 2 
S.D.) VSMC counts per HPF were 115 (17) for control 
60 - sensitised arteries; 103 (8) for laser alone treated un- 
8 sensitised arteries; and 27 (29) (p<0.0001) for arteries 
harvested at either 3 or 14 days following PDT. 
40 - Comparing PDT at different time points (drug-light 
intervals) showed that the maximal effect (as measured 
by VSMC depletion in the media) was seen at 1.5 
20 ~ and 6-7h post sensitisation, corresponding with the 
pharmacoklnetic profile of PpIX as seen in Fig. 3. From 
tissue harvested at 3 days, mean (+2 S.D.) VSMC/ 
0 I ~ I ,  [ ,  I p I ,  I r I ,  I ,  [ ,  r ,  I ~ 
2 4 6 8 10 12 14 16 18 20 22 24 HPF in treatment groups, compared with controls, 
Time (h) were reduced at all time points; 22 (19) (p<0.0001) at 
1.5h; 51 (29) (p<0.0001) at 2.5h and 11 (10) (p<0.0001) 
Fig. 3. Graph showing the temporal profile of fluorescence (ex- at 6-7h as seen in Fig. 5, but depletion appeared to 
pressed as a mean plxel count) for each arterial layer at time points 
0 to 24h following 5-ALA administration at 120mg/kg. ([]) Intlma, be most at times corresponding to the first adventitial 
(A) me&a, (O) advent~tla peak and the later medial peak. 
Arterial segments treated at the same drug light 
interval, but harvested either at 3 or 14 days were 
points (Fig. 2) PpIX activity as measured by fluor- analysed separately (Fig. 6). Mean VSMC/HPF (+2 
escence was seen to exhibit a double peak in the S.D.) from treatment groups harvested at 3 days (8 
adventitia, initially at 1.5h and again at 4h. Fluor- (12)) and 14 days (17 (19)) were significantly (p<0.0001) 
escence peaked in the media at 6h and showed a reduced compared with controls. 
steady rise in the intima to 4h followed by a plateau The presence or absence of endothelial cells was 
from 4 to 8h (Fig. 3). assessed using polyclonal Factor VIII as a marker 
which showed complete absence of endothelial cells 
from sections harvested at 3 days, but repopulation 
Histology and morphometry of PDT treated arteries by day 14. Endothelial cell repopulation occurred early, 
but VSMC depletion persisted at 14 days and no 
All animals survived to culling and there was no appreciable neointimalhyperplasla occurred m treated 
evidence of thrombosis, rupture or aneurysm for- sections. 
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Fig. 4. Transverse haematoxyhn and eosm sections (40 x objective, hght microscopy) of a swine lhac artery (a) following treatment with 
PDT and (b) following a control laser alone lrradmtxon The arrow shows the presence of abundant VSMC nuclei m the control section 
with almost complete depletion m he PDT section. 
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Fig. 5. Bar chart showing mean cell counts per HPF for control Fig. 6. Bar chart showing mean cell counts per HPF for control and 
vessels and those xposed to PDT at 1 5, 2 5 and 6-7h following treated vessels harvested at 3 and 14 days followmg PDT at the 
sensltlsatlon from ammals sacrificed at 3 days Error bars represent same drug hght intervals. Error bars represent standard devlahons 
standard deviations (m) ALA control, ([2]) laser control, ([]) PDT (R) ALA control, ([~) laser control, ([]) PDT-3 days, ([]) PTD-14 
@ 1 5h, (~) PDT @ 25h, ([]) PDT @ 6-7h days 
Discussion the peak m the me&a being three times that of the 
mtima or adventitia. The large animal data presented 
This study has established the pharmacoklnetics of 5- here, not only shows that the peak activity level within 
ALA in the pig model, shown that endovascular light the media occurs between 5-8h, but also reveals that 
delivery is feasible and that vascular PDT results in an equivalent peak occurs in the adventitia, but much 
medial VSMC depletion. Endothelial cell regeneration earlier. 
occurred whilstVSMC depletlon persisted and despite This has important implications, firstly for the 
a period of endothelial denudation, no neomtimal timing of PDT to reduce intimal hyperplasia and 
hyperplasla occurred. The pharmacokinehc studies secondly, the differential photosensitisation of the 
showed that a peak in PpIX activity in the media arterial wall raises the possiblhty that PDT could be 
occurred much later than that expected from small used as an investigative tool for studying the role 
ammal data. In Nyamekye's work 23 using 5-ALA in of individual wall layers in the restenosis process 
the rat carotid model, peak PpIX activity occurred at It has already been suggested that the adventitia 
lh  post-dose m all layers, but differred in magnitude, plays a more important role m restenosis than 
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previously thought, 28'29 but current echniques avail- treatment area. The development of a transparent 
able for studying the adventitia in isolation are PTA balloon has facilitated this and also established 
rudimentary. B° that the intra-arterial delivery of PDT with 5-ALA 
From the above pharmacokinetic studies, PDT was as a sensitiser is feasible and effective. Moreover, 
given at a number of time points to coincide with use of equipment currently used in clinical practice 
maximal sensitiser activity in the adventltia, then will make a clinical trial of the technique a practical 
media, and finally when activity was at a minimum, prospect with minimal modification. In the present 
The results of these experiments confirm the data study, up to 1950s were needed to produce 50 J/ 
from small animal studies, i.e. that PDT can exert c In  2 over  the 4cm length of the balloon, but in recent 
an effect on the media which results in VSMC studies, optimisatlon of laser function has reduced 
depletion. Treatments at 5-7h post-dose showed a this time to 500s. 
significant reduction in the number of VSMCs within No complications were seen in any of the treated 
the media compared with controls. What is perhaps or control pigs. In particular, neither acute thrombosis 
more surprising is that PDT given at 1.5h post nor aneurysmal formation occurred. Although one 
sensitiser (coinciding with a peak in adventitlal may not expect the latter to have occurred in the 
activity) produced a similar depletion in the medial time frame studied, there is evidence that the cellular 
VSMC population. An obvious explanation for such depletion caused by PDT does not influence the 
an effect would be that the outcome as measured mechanical integrity of the arterial wall. Grant 32 has 
was far too sensitive and that PDT at any time after shown that the bursting pressure of arteries following 
photosensitlsation would produce the same effect. If PDT treatment using 5-ALA is no different from 
this was the case however, treating at 2-2.5h (with that of controls. Thrombosis, if it was going to occur, 
minimum activity in all layers) would lead to a would have been most likely in the first week, as 
comparable VSMC depletion. Although PDT at this there was denudation of the endothelial layer at 3 
time does show some depletion compared with days. All pigs were given heparin intraoperatively 
controls, it is of the order of 50% rather than 90% and aspirin perioperatively and by 14 days, marker 
depletion obtained at the other time points. The studies showed complete re-endothehalisation. It 
above variation in efficacy of PDT with time mirrors would therefore be unlikely that thrombosis would 
the fluorescence profile of 5-ALA, which lends occur later than this. 
validity to the observation that PDT at a time of Therapies directed purely at inhibiting neointimal 
selective adventitial sensitisation can cause medial hyperplasia have subsequently failed to prevent re- 
call depopulation. This may be due to a direct stenosis clinically and in large animal models. The 
effect by oxygen radicals generated in the adventltia emergence of remodelling as a concept was used as 
causing medial cell death or may be indirect, with an explanation for the failure of such therapies to 
adventitial cell death impairing nutrition of the completely abolish restenosis. Stenting inhibits both 
media, immediate negative recoil and remodelling. This work 
For PDT to be a practical adjunctive treatment to does not address the influence of PDT on the arterial 
prevent restenosis after PTA, it would have to be response to injury and remodelhng, but does show 
delivered at the time of PTA and via a percutaneous that persistent VSMC depletion can be achieved whilst 
technique. Previous vascular PDT studies have relied allowing re-endothelialisation. This may prove par- 
on external irradiation of an open artery, although tlcularly useful as a therapy to reduce the incidence 
Nyamekye et aI. 2B did experiment with an intra- of in-stent restenosis which is almost exclusively sec- 
arterial laser fibre. As well as satisfying the minimally ondary to intimal hyperplasia. 16 Currently there is 
lnvasive principles imperative in any percutaneous much interest in ionising brachytherapy as a means 
technique, intraluminal ight delivery via a PTA of reducing restenosis gB-s5 and although early clinical 
balloon would solve two important problems; that results look promising, B6the known long-term effects 
of centring and excluding blood from the treatment of ionislng irradiation may point to problems in the 
field. Vincent 31 has previously established that blood future. B7 It is possible that endovascular PDT using 5- 
significantly limited the transmission of red light, "ALA as a sensitiser is a safer but just as efficacious 
but the ability to irradiate via an inflated balloon alternative. 
effectively isolates a blood-free segment of arterial In conclusion, this study confirms the efficacy of 
wall for treatment. At the same time, the radially ~rascular PDT using 5-ALA as a photosensitiser in the 
diffusing laser fibre within the central channel of the pig model. It shows that endovascular delivery of light 
balloon leads to a relatively uniform circumferential via an appropriate PTA balloon is practical and does 
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not  g ive  r ise to th rombot ic  compl i ca t ions .  We have  after coronary angloplasty. A serial mtravascular ultrasound 
study Ctrculatmn 1996, 94 3543 
s ince es tab l i shed  the  e f fec t iveness  of  PDT in  reduc ing  15 Rub ANDERSON H, MAENG M, THORWEST M, FALK E Remodeling 
in t ima l  hyperp las ia  us ing  the same techn ique  in a rather than neomtlmal formation explains lummal narrowing 
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